More than six years following the start of the Covid pandemic, millions of individuals continue to experience long Covid symptoms. Researchers at University College London and University College London Hospitals conducted a clinical trial examining potential treatments for the condition. The study evaluated over-the-counter antihistamines combined with colchicine, a prescription anti-inflammatory medication, finding that these interventions produced a small reduction in fatigue among participants. Researchers cautioned that while the results represent a modest step forward, the treatment does not constitute a cure for long Covid.
Professor Danny Altmann, an immunologist at Imperial College London, discussed the new research findings and highlighted challenges in comprehending the condition. He also addressed several forthcoming studies that may advance understanding of long Covid and potential management strategies.
In separate health-related developments, approximately one in 335 people in the UK are living with a stoma. According to Colostomy UK, more than 60 per cent of individuals with a stoma report that inadequate toilet facilities negatively affect their daily activities. Following a campaign originating in Bristol, the retail chain B&Q implemented modifications to make disabled toilets across its stores more suitable for people with stomas. The initiative involved collaboration with individuals living with stomas and medical professionals from Bristol Foundation Trust.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI